CTOS 2020 was conducted virtually from November 18th through the 21st, given the nature of our current environment, much of the content of the conference centered on COVID-19 and its impact on cancer patients, but there were a number of sessions and presentations and posters devoted to GIST as well.
Each member has a unique story, but all reflect the intrinsic courage of one facing the challenge of GIST. Stephanie De Jong shares her story.
The New Horizons GIST 2020 Virtual Meeting kicked off on Thursday September 10th at 8am EST. Meeting since 2003, these patient advocates for various cancers split off to a GIST-only meeting several years ago. This year’s meeting, originally planned for Berlin, Germany, was held virtually September 10-12th.
Fundación GIST México celebrated GIST Awareness Day with these actitivities: Spot on local radio. "GISTJuntos" This spot which was broadcast 4 times a day from July 8th to [...]
Medicamentos actuales y emergentes “Existen muchas opciones terapéuticas disponibles, pero sigue siendo un desafío hacer coincidir el medicamento correcto con el paciente correcto” Recuerdo en mi memoria ... es junio de 2016, y acabo [...]
LRG’s Senior Director of Research, Pete Knox has summarized the ten key studies relating to GIST that are being presented at the American Society of Clinical Oncology's Annual meeting. ASCO20 is virtual this year.
page created 5/18/2020 Qinlock Approved for 4th Line GIST Treatment May 15, 2020 QinlockTM (ripretinib) (Deciphera Pharmaceuticals, LLC) was approved by the FDA for adult patients with advanced gastrointestinal stromal tumor (GIST) who have [...]
Many GIST patients around the world struggle with getting the treatment they need to survive and thrive. Arun Krishnan’s story illustrates how collaboration between patient groups and doctors across the globe can affect patient survival.
During this webcast presentation, Dr. Michael Heinrich will discuss these two new treatment options for advanced GIST. Dr. Heinrich will explain how each of these drugs works to target mutations for which there has previously been no targeted treatment and discuss the current coronavirus outbreak.
Each member has a unique story, but all reflect the intrinsic courage of one facing the challenge of GIST. Alan Henderson shares his story.
If you didn't find what you were looking for, try a new search!
